Xlife Sciences AG (XLS) | WebDisclosure

PRESS RELEASE

published on 11/28/2025 at 13:10, 8 months 24 days ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 10 months 6 days ago

Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable

Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF

published on 10/16/2025 at 07:05, 10 months 6 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 10 months 6 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF

published on 09/23/2025 at 07:05, 10 months 29 days ago

Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025

Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF

published on 09/23/2025 at 07:05, 10 months 29 days ago

Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025

Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE

published on 09/23/2025 at 07:00, 10 months 29 days ago

Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025

Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF

published on 07/17/2025 at 07:05, 1 year 1 month ago

VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4

Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF

published on 07/17/2025 at 07:05, 1 year 1 month ago

VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing

Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE

published on 07/17/2025 at 07:00, 1 year 1 month ago

Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey

Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4

Published on 08/22/2026 at 05:50, 22 hours 29 minutes ago

Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 23 hours 24 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 3 hours ago

BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 1 day 5 hours ago

Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 1 day 5 hours ago

Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott

View all ACCESSWIRE

Published on 08/21/2026 at 19:36, 1 day 8 hours ago

EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 9 hours ago

EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 1 day 10 hours ago

EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 day 11 hours ago

BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades

View all EQS

Published on 08/21/2026 at 18:33, 1 day 9 hours ago

260821 BENETEAU Transaction sur actions propres
Published on 08/21/2026 at 08:30, 1 day 19 hours ago

Thales issues a €1bn bond
Published on 08/21/2026 at 08:30, 1 day 19 hours ago

Thales émet un emprunt obligataire de 1 Md€
Published on 08/18/2026 at 18:00, 4 days 10 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 4 days 10 hours ago

Mise à disposition du rapport financier annuel 2025-26

View all LES ECHOS COMFI WIRE

News